# Clinical trials recruiting in Illinois: 2,830 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 2,830 trials recruiting or not yet recruiting with a site in Illinois, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Illinois: 2,830 rows for $108.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 49 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/illinois

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 2,830
- Recruiting or not yet: 2,830
- Read on: November 19, 2026

## Trials

The 25 newest of 2,830, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945041 | Optimizing Acute Care Rehabilitation for Critically Ill Adults | University of Colorado, Denver | Not applicable | Not yet recruiting | ICU Acquired Muscle Weakness, Critical Illness, Functional Impairment, Rehabilitation After Critical Illness | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945041) |
| November 17, 2026 | NCT07941739 | Kindness Matters: Evaluating the Impact of a Classroom Kindness Intervention | University of Illinois Chicago | Not applicable | Not yet recruiting | Prosocial Behavior, Social Competence, Burnout, Professional, Happiness | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941739) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 16, 2026 | NCT07937982 | Protocol CAUSE-05 RHINO | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Not yet recruiting | Asthma, Respiratory Health | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937982) |
| November 13, 2026 | NCT07936266 | Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R... | Sponsor not shown (see the record) | Phase 1 | Recruiting | B-cell Acute Lymphoblastic Leukemia (B-ALL) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936266) |
| November 13, 2026 | NCT07935616 | Zileuton for Food Allergy | Sponsor not shown (see the record) | Phase 1 | Recruiting | Food Allergies | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935616) |
| November 13, 2026 | NCT07935564 | A Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants. | AbbVie | Phase 1 | Not yet recruiting | Healthy Volunteer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935564) |
| November 13, 2026 | NCT07934680 | Mental Health Link for Veterans Referred to Mental Health Services | VA Office of Research and Development | Not applicable | Not yet recruiting | Depression | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934680) |
| November 12, 2026 | NCT07932717 | Comprehensive Lung Health | Northwestern University | Not applicable | Recruiting | Respiratory Illness | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932717) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 10, 2026 | NCT07927946 | Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | SCHIZOPHRENIA 1 (Disorder) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927946) |
| November 9, 2026 | NCT07925983 | A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants | AbbVie | Phase 1 | Recruiting | Healthy Volunteer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925983) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 6, 2026 | NCT07922460 | Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS) | University of Illinois Chicago | Phase 3 | Not yet recruiting | Proliferative Sickle Cell Retinopathy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922460) |
| November 6, 2026 | NCT07922122 | Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI | TryAbility LLC | Not applicable | Recruiting | Spinal Cord Injuries | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922122) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07917728 | Smartphone Enabled Detection of Cognitive Motor Dissociation in the ICU | Columbia University | Observational | Recruiting | Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Cardiac Arrest (CA) | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917728) |
| November 4, 2026 | NCT07916480 | Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis | Arcutis Biotherapeutics, Inc. | Phase 3 | Recruiting | Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | 415 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916480) |
| November 4, 2026 | NCT07916259 | The Study of Brave-LC LDN Treatment Trial | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Post-acute COVID-19 Syndrome | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916259) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Northwestern University | Chicago | 374 |
| University of Chicago | Chicago | 187 |
| Rush University Medical Center | Chicago | 155 |
| Southern Illinois University School of Medicine | Springfield | 121 |
| Carle Cancer Center | Urbana | 118 |
| University of Chicago Medical Center | Chicago | 110 |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | 109 |
| Carle Physician Group-Effingham | Effingham | 107 |
| Carle Physician Group-Mattoon/Charleston | Mattoon | 106 |
| Springfield Clinic | Springfield | 102 |
| Decatur Memorial Hospital | Decatur | 101 |
| University of Illinois | Chicago | 97 |
| University of Chicago Comprehensive Cancer Center | Chicago | 96 |
| Cancer Care Specialists of Illinois - Decatur | Decatur | 95 |
| Loyola University Medical Center | Maywood | 95 |
| Cancer Care Center of O'Fallon | O'Fallon | 92 |
| Illinois CancerCare-Pekin | Pekin | 87 |
| Illinois CancerCare-Peoria | Peoria | 85 |
| Springfield Memorial Hospital | Springfield | 85 |
| Illinois CancerCare-Bloomington | Bloomington | 84 |
| Illinois CancerCare-Galesburg | Galesburg | 84 |
| Illinois CancerCare-Macomb | Macomb | 84 |
| Illinois CancerCare-Ottawa Clinic | Ottawa | 84 |
| Illinois CancerCare-Peru | Peru | 84 |
| Crossroads Cancer Center | Effingham | 84 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 28 |
| Phase 1 | 195 |
| Phase 1/2 | 167 |
| Phase 2 | 491 |
| Phase 2/3 | 74 |
| Phase 3 | 659 |
| Phase 4 | 96 |
| Not applicable | 678 |
| Observational | 442 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 107 |
| Breast Neoplasms | 88 |
| Neoplasms | 78 |
| Lung Neoplasms | 70 |
| Prostatic Neoplasms | 69 |
| Obesity | 64 |
| Neoplasm Metastasis | 57 |
| Colorectal Neoplasms | 56 |
| Ovarian Neoplasms | 49 |
| Heart Failure | 45 |
| Overweight | 43 |
| Endometrial Neoplasms | 41 |
| Stroke | 38 |
| Recurrence | 38 |
| Diabetes Mellitus, Type 2 | 36 |
| Leukemia, Myeloid, Acute | 35 |
| Pancreatic Neoplasms | 35 |
| Multiple Myeloma | 35 |
| Squamous Cell Carcinoma of Head and Neck | 33 |
| Depression | 33 |
| Urinary Bladder Neoplasms | 33 |
| Cardiovascular Diseases | 32 |
| Hypertension | 30 |
| Schizophrenia | 27 |
| Colitis, Ulcerative | 26 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Chicago | 163 |
| Northwestern University | 159 |
| University of Illinois Chicago | 114 |
| National Cancer Institute (NCI) | 92 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 74 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 57 |
| Rush University Medical Center | 50 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 49 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 38 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 36 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 35 |
| SWOG Cancer Research Network | 30 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 29 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 28 |
| VA Office of Research and Development | 27 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 27 |
| Endeavor Health | 25 |
| Alliance for Clinical Trials in Oncology | 24 |
| Children's Oncology Group | 24 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 23 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 22 |
| NRG Oncology | 21 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 21 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 20 |
| University of Illinois at Urbana-Champaign | 18 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Illinois

- [Private investigators in Illinois, United States](https://specstream.ai/data/businesses/private-investigators/illinois-united-states)
- [Water softening equipment suppliers in Illinois, United States](https://specstream.ai/data/businesses/water-softening-equipment-suppliers/illinois-united-states)
- [Cleaning companies in Illinois, United States](https://specstream.ai/data/businesses/cleaning-companies/illinois-united-states)
- [Glass companies in Illinois, United States](https://specstream.ai/data/businesses/glass-companies/illinois-united-states)
- [Nephrology practices in Illinois, United States](https://specstream.ai/data/businesses/nephrology-practices/illinois-united-states)
- [Software development companies in Illinois, United States](https://specstream.ai/data/businesses/software-development-companies/illinois-united-states)
